Reconstructed Bone (r-Bone™) 3D Cell Culture Service, Mulitiple Myeloma
zPREDICTAHuman, bone marrow 3D culture model enabling accurate testing of therapeutic agents against multiple myeloma.
Products, services, reviews and techniques used in the identification and validation of the disease-causing target genes and proteins.
Human, bone marrow 3D culture model enabling accurate testing of therapeutic agents against multiple myeloma.
Human, bone marrow 3D culture model enabling accurate testing of therapeutic agents against acute myelogenous leukemia (AML).
Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications.
Novel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications.
The µPAC™ capLC columns are designed for increased robustness and throughput assuring sensitivity. A flow rate versatility between 1 and 15 µL/min at moderated pressures allows short gradient separations, while the µPAC™ technology ensures an exceptional high reproducibility over time and across laboratories. µPAC™ column, 50cm length, with pillar array backbone at interpillar distance of 2.5 µm, C18.
The MuviCyte™ live-cell imaging system is designed to operate inside your cell-culture incubator, enabling you to maintain your cells under optimal conditions and perform a wide range of assays in a variety of culture vessels.
The Native Antigen Company offers a selection of complementary easy-to-use antibody conjugation formats, with a wide range of labels suitable for use in most applications. On request we can also undertake custom conjugation of proteins and antibodies.